HCV Vaccine Development

Module number
 
Date presented
July 17, 2018 
Duration
46:57 
Audience
 
CE Credit
 

On Tuesday, July 17th, Dr. Andrea Cox of Johns Hopkins University presented on: “HCV Vaccine Development”

About Dr. Cox:
Andrea Cox is currently a Professor of Medicine and Oncology at the Johns Hopkins School of Medicine in Baltimore, MD. She earned her Ph.D. studying T cell immunology at The University of Virginia. She subsequently completed an M.D. and then Internal Medicine and Infectious Disease training at Johns Hopkins. Clinically, she specializes in the treatment of patients with hepatitis virus infections and HIV. Her laboratory investigates human immune responses to HCV, HBV, and HIV, including mechanisms through which these chronic viral infections stimulate and evade immune responses, and in HCV vaccine development. She has been an active participant in clinical trials of direct-acting antivirals for the treatment of hepatitis C virus. She is a principal investigator on the first prophylactic HCV vaccine trial ever implemented in an at-risk population.

Access the slides here